increase capacity of medical/ healthcare services in the future, this expansion will not affect the medical services, the Company and shareholder in the long term. 7. Sources of Fund Working capital and/or
increase capacity of medical/ healthcare services in the future, this expansion will not affect the medical services, the Company and shareholder in the long term. 7. Sources of Fund Working capital and/or
Credit (SBLC) in the amount of up to USD 50 Million by the Company to Indo Rama Synthetics (India) Limited (“IRSL”), a connected party. Rationale of the transaction: Post-acquisition of equity stake and
Contractual Party and its Relationship with the Company 1. Transaction to the Lands Owner of the land: Mrs.Thaneiya Kantapichan Buyer: The Company Limited or its Subsidiary, the company will be set up a wholly
company will be set up a wholly- owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor : N/A 3. Buying the Medical Instruments The Company will appropriately
company will be set up a wholly-owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor : N/A 3. Buying the Medical Instruments The Company will appropriately
PERIOD ENDED 30 SEPTEMBER 2017 1. Highlights Health and safety: There were zero lost time injuries in Q3 2017 Revenue: 202.67mTHB in Q3 2017 compared to 183.67mTHB in Q3 2016 an increase of 10.3%; 2017
amounted to THB 646 million, increased by THB 4 million or 0.7% representing 32% gross profit margin, up from 31.3% gross profit margin in the corresponding period last year. The increase in gross profit
million in 3Q2018, representing an increase of THB 117.30 million or 2.67% up from 3Q2017 mainly from higher revenue from chicken processing segment and farm & DOC segment which increased by 5. 06% and 6
Media Public Company Limited No. 2 (VGI-W2), Capital Increase through a General Mandate and Calling the 2018 Annual General Meeting of Shareholders To The President The Stock Exchange of Thailand